Tag: Symvess
Humacyte’s Symvess supports high rates of limb salvage at 36 months...
Humacyte recently announced the presentation of 36-month data assessing the durability of its Symvess acellular tissue-engineered vessel in extremity arterial trauma patients. The results...
